- Home
- Publications
- Publication Search
- Publication Details
Title
Mechanisms and Therapy for Cancer Metastasis to the Brain
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-24
DOI
10.3389/fonc.2018.00161
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overall Survival in Patients With Advanced Melanoma Who Received Nivolumab Versus Investigator’s Choice Chemotherapy in CheckMate 037: A Randomized, Controlled, Open-Label Phase III Trial
- (2018) James Larkin et al. JOURNAL OF CLINICAL ONCOLOGY
- Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism
- (2018) Gary E. Raskob et al. NEW ENGLAND JOURNAL OF MEDICINE
- The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis
- (2017) Fausto Petrelli et al. EUROPEAN JOURNAL OF CANCER
- Efficacy of the combination of ipilimumab and nivolumab following progression on pembrolizumab in advanced melanoma with poor risk features
- (2017) Lavinia Spain et al. EUROPEAN JOURNAL OF CANCER
- Afatinib Therapy for Brain Metastases Aggravated by a Reduction in the Dose of Erlotinib Due to the Development of Hepatotoxicity
- (2017) Yumie Yamanaka et al. INTERNAL MEDICINE
- Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial
- (2017) Thomas M. Churilla et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA)
- (2017) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: Rational and progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Osimertinib in Pretreated T790M-Positive Advanced Non–Small-Cell Lung Cancer: AURA Study Phase II Extension Component
- (2017) James Chih-Hsin Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase–Positive Non–Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial
- (2017) Dong-Wan Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Applications of DNA-Based Liquid Biopsy for Central Nervous System Neoplasms
- (2017) Joanna Wang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Anticoagulation for the treatment of venous thromboembolism in patients with brain metastases: a meta-analysis and systematic review
- (2017) Bradley D. Hunter et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
- (2017) Jean-Charles Soria et al. LANCET
- Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006)
- (2017) Jacob Schachter et al. LANCET
- Alectinib versus crizotinib in patients with ALK -positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial
- (2017) Toyoaki Hida et al. LANCET
- Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial
- (2017) Paul D Brown et al. LANCET ONCOLOGY
- Lorlatinib in non-small-cell lung cancer with ALK or ROS1 rearrangement: an international, multicentre, open-label, single-arm first-in-man phase 1 trial
- (2017) Alice T Shaw et al. LANCET ONCOLOGY
- Treatment options for EGFR mutant NSCLC with CNS involvement—Can patients BLOOM with the use of next generation EGFR TKIs?
- (2017) Chee-Seng Tan et al. LUNG CANCER
- Paradigm shift of therapeutic management of brain metastases in EGFR-mutant non-small cell lung cancer in the era of targeted therapy
- (2017) Akimasa Sekine et al. MEDICAL ONCOLOGY
- Diagnosis and treatment of brain metastases from solid tumors: guidelines from the European Association of Neuro-Oncology (EANO)
- (2017) Riccardo Soffietti et al. NEURO-ONCOLOGY
- Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors
- (2017) Xuling Lin et al. NEURO-ONCOLOGY
- Three or More Courses of Stereotactic Radiosurgery for Patients with Multiply Recurrent Brain Metastases
- (2017) Rupesh Kotecha et al. NEUROSURGERY
- Treatment of brain metastases in the modern genomic era
- (2017) Ibiayi Dagogo-Jack et al. PHARMACOLOGY & THERAPEUTICS
- Stereotactic radiosurgery versus whole-brain radiotherapy after intracranial metastasis resection: a systematic review and meta-analysis
- (2017) Nayan Lamba et al. Radiation Oncology
- Icotinib versus whole-brain irradiation in patients with EGFR -mutant non-small-cell lung cancer and multiple brain metastases (BRAIN): a multicentre, phase 3, open-label, parallel, randomised controlled trial
- (2017) Jin-Ji Yang et al. Lancet Respiratory Medicine
- Erlotinib and bevacizumab in patients with advanced non-small-cell lung cancer and activating EGFR mutations (BELIEF): an international, multicentre, single-arm, phase 2 trial
- (2017) Rafael Rosell et al. Lancet Respiratory Medicine
- Estimating Survival in Patients With Lung Cancer and Brain Metastases
- (2017) Paul W. Sperduto et al. JAMA Oncology
- Concurrent Afatinib and Whole-Brain Radiotherapy in Exon 19-del-EGFR Mutant Lung Adenocarcinoma: A Case Report and Mini Review of the Literature
- (2017) Chukwuka Eze et al. Frontiers in Oncology
- Vemurafenib in Metastatic Melanoma Patients with Brain Metastases: An Open-Label, Single-Arm, Phase 2, Multicentre Study
- (2016) GA McArthur et al. ANNALS OF ONCOLOGY
- Histopathologic diagnosis of brain metastases: current trends in management and future considerations
- (2016) Lien Bekaert et al. Brain Tumor Pathology
- Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab
- (2016) Onder Tonyali et al. BREAST
- Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery
- (2016) Jack M. Qian et al. CANCER
- Techniques d’imagerie utilisées dans le diagnostic différentiel entre radionécrose cérébrale et rechute tumorale après irradiation en conditions stéréotaxiques de métastases cérébrales : revue de la littérature
- (2016) I. Menoux et al. Cancer Radiotherapie
- Ipilimumab Combined with Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
- (2016) Matteo S. Carlino et al. CLINICAL CANCER RESEARCH
- Preclinical Comparison of Osimertinib with Other EGFR-TKIs in EGFR-Mutant NSCLC Brain Metastases Models, and Early Evidence of Clinical Brain Metastases Activity
- (2016) P. Ballard et al. CLINICAL CANCER RESEARCH
- Metastatic melanoma treatment: Combining old and new therapies
- (2016) Ryan J. Davey et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Treatment of brain metastasis
- (2016) Roberta Rudà et al. CURRENT OPINION IN ONCOLOGY
- Imaging and Clinical Profile Following Concurrent Stereotactic Radiation and Immune Therapy for Melanoma Brain Metastases: Preliminary Results
- (2016) C. Shen et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Surgical Resection of Brain Metastases and the Risk of Leptomeningeal Recurrence in Patients Treated With Stereotactic Radiosurgery
- (2016) Matthew D. Johnson et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Single-Fraction Versus Multifraction (3 × 9 Gy) Stereotactic Radiosurgery for Large (>2 cm) Brain Metastases: A Comparative Analysis of Local Control and Risk of Radiation-Induced Brain Necrosis
- (2016) Giuseppe Minniti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases
- (2016) Paul D. Brown et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
- (2016) Elena I. Pentsova et al. JOURNAL OF CLINICAL ONCOLOGY
- Translational Breast Cancer Research Consortium (TBCRC) 022: A Phase II Trial of Neratinib for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases
- (2016) Rachel A. Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II Study of Whole-Body and Intracranial Activity With Ceritinib in Patients WithALK-Rearranged Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy and Crizotinib: Results From ASCEND-2
- (2016) Lucio Crinò et al. JOURNAL OF CLINICAL ONCOLOGY
- Veliparib in combination with whole-brain radiation therapy for patients with brain metastases from non-small cell lung cancer: results of a randomized, global, placebo-controlled study
- (2016) Pierre Chabot et al. JOURNAL OF NEURO-ONCOLOGY
- Response of symptomatic brain metastases from HER-2 overexpressing breast cancer with T-DM1
- (2016) C. L. Gorter de Vries et al. JOURNAL OF NEURO-ONCOLOGY
- Comparing pre-operative stereotactic radiosurgery (SRS) to post-operative whole brain radiation therapy (WBRT) for resectable brain metastases: a multi-institutional analysis
- (2016) Kirtesh R. Patel et al. JOURNAL OF NEURO-ONCOLOGY
- P2.36: Nivolumab (nivo) in Patients (pts) With Advanced (adv) NSCLC and Central Nervous System (CNS) Metastases (mets)
- (2016) Jonathan W. Goldman et al. Journal of Thoracic Oncology
- First-Line Afatinib versus Chemotherapy in Patients with Non–Small Cell Lung Cancer and Common Epidermal Growth Factor Receptor Gene Mutations and Brain Metastases
- (2016) Martin Schuler et al. Journal of Thoracic Oncology
- Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial
- (2016) Paula Mulvenna et al. LANCET
- Activity and safety of brigatinib in ALK -rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial
- (2016) Scott N Gettinger et al. LANCET ONCOLOGY
- Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
- (2016) Sarah B Goldberg et al. LANCET ONCOLOGY
- Dabrafenib plus trametinib in patients with previously treated BRAF V600E -mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial
- (2016) David Planchard et al. LANCET ONCOLOGY
- Intracranial response to nivolumab in NSCLC patients with untreated or progressing CNS metastases
- (2016) Elizabeth Dudnik et al. LUNG CANCER
- DynamicO-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy
- (2016) Garry Ceccon et al. NEURO-ONCOLOGY
- Updates in the management of brain metastases
- (2016) Nils D. Arvold et al. NEURO-ONCOLOGY
- 215 Postoperative Stereotactic Radiosurgery vs Observation for Completely Resected Brain Metastases
- (2016) Ganesh Rao et al. NEUROSURGERY
- AZD3759, a BBB-penetrating EGFR inhibitor for the treatment of EGFR mutant NSCLC with CNS metastases
- (2016) Z. Yang et al. Science Translational Medicine
- New Therapeutic Opportunities Based on DNA Mismatch Repair and BRAF Status in Metastatic Colorectal Cancer
- (2016) Romain Cohen et al. Current Oncology Reports
- Local Tumor Treatment in Combination with Systemic Ipilimumab Immunotherapy Prolongs Overall Survival in Patients with Advanced Malignant Melanoma
- (2016) S. Theurich et al. Cancer Immunology Research
- Radiotherapy plus EGFR TKIs in non-small cell lung cancer patients with brain metastases: an update meta-analysis
- (2016) Tao Jiang et al. Cancer Medicine
- Embracing rejection: Immunologic trends in brain metastasis
- (2016) S. Harrison Farber et al. OncoImmunology
- Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
- (2015) K. A. Ahmed et al. ANNALS OF ONCOLOGY
- Balancing bleeding in brain metastases
- (2015) L. B. Kreuziger BLOOD
- Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer
- (2015) Jin Sun Lee et al. BREAST CANCER RESEARCH AND TREATMENT
- Épidémiologie des lésions métastatiques cérébrales
- (2015) S. Taillibert et al. Cancer Radiotherapie
- Activity of T-DM1 in Her2-positive breast cancer brain metastases
- (2015) Rupert Bartsch et al. CLINICAL & EXPERIMENTAL METASTASIS
- Bevacizumab Preconditioning Followed by Etoposide and Cisplatin Is Highly Effective in Treating Brain Metastases of Breast Cancer Progressing from Whole-Brain Radiotherapy
- (2015) Y.-S. Lu et al. CLINICAL CANCER RESEARCH
- Diagnostic imaging of intracranial metastasis
- (2015) Stephen F. Kralik et al. CURRENT PROBLEMS IN CANCER
- Predictive role of BRAF mutations in patients with advanced colorectal cancer receiving cetuximab and panitumumab: A meta-analysis
- (2015) Filippo Pietrantonio et al. EUROPEAN JOURNAL OF CANCER
- Screening, resilience, patient navigation and information needs - key areas in cancer control
- (2015) D. Weller EUROPEAN JOURNAL OF CANCER CARE
- Differentiation of high-grade-astrocytomas from solitary-brain-metastases: Comparing diffusion kurtosis imaging and diffusion tensor imaging
- (2015) Yan Tan et al. EUROPEAN JOURNAL OF RADIOLOGY
- Testing for oncogenic molecular aberrations in cell-free DNA-based liquid biopsies in the clinic: are we there yet?
- (2015) Jiri Polivka et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS
- (2015) David B. Shultz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Competing Risk Analysis of Neurologic versus Nonneurologic Death in Patients Undergoing Radiosurgical Salvage After Whole-Brain Radiation Therapy Failure: Who Actually Dies of Their Brain Metastases?
- (2015) John T. Lucas et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
- (2015) Arjun Sahgal et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment
- (2015) Ana P. Kiess et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Leukoencephalopathy After Stereotactic Radiosurgery for Brain Metastases
- (2015) Daniel M. Trifiletti et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Clinical Experience With Crizotinib in Patients With Advanced ALK-Rearranged Non–Small-Cell Lung Cancer and Brain Metastases
- (2015) Daniel B. Costa et al. JOURNAL OF CLINICAL ONCOLOGY
- Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial
- (2015) Stephen R. Rapp et al. JOURNAL OF CLINICAL ONCOLOGY
- NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases.
- (2015) Paul D. Brown et al. JOURNAL OF CLINICAL ONCOLOGY
- Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014
- (2015) Gary H. Lyman et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Do Circulating Tumor Cells, Exosomes, and Circulating Tumor Nucleic Acids Have Clinical Utility?
- (2015) Bert Gold et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- The brain metastatic niche
- (2015) Frank Winkler JOURNAL OF MOLECULAR MEDICINE-JMM
- Hypofractionated radiosurgery has a better safety profile than single fraction radiosurgery for large resected brain metastases
- (2015) Bree R. Eaton et al. JOURNAL OF NEURO-ONCOLOGY
- Veliparib in combination with whole brain radiation therapy in patients with brain metastases: results of a phase 1 study
- (2015) Minesh P. Mehta et al. JOURNAL OF NEURO-ONCOLOGY
- Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases
- (2015) Zachary A. Kohutek et al. JOURNAL OF NEURO-ONCOLOGY
- Impact of surgical methodology on the complication rate and functional outcome of patients with a single brain metastasis
- (2015) Akash J. Patel et al. JOURNAL OF NEUROSURGERY
- Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance
- (2015) Jodi M Saunus et al. JOURNAL OF PATHOLOGY
- Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial
- (2015) Georgina V Long et al. LANCET
- Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trial
- (2015) Javier Cortés et al. LANCET ONCOLOGY
- Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
- (2015) James Chih-Hsin Yang et al. LANCET ONCOLOGY
- Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
- (2015) Jeffrey S Weber et al. LANCET ONCOLOGY
- Tumor Progression in Patients Receiving Adjuvant Whole-Brain Radiotherapy vs Localized Radiotherapy After Surgical Resection of Brain Metastases
- (2015) Jason Hsieh et al. NEUROSURGERY
- Improved Overall Survival in Melanoma with Combined Dabrafenib and Trametinib
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
- (2015) Sandra M. Swain et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases
- (2015) J. J. Harding et al. ONCOLOGIST
- Cerebrospinal fluid-derived circulating tumour DNA better represents the genomic alterations of brain tumours than plasma
- (2015) Leticia De Mattos-Arruda et al. Nature Communications
- Genomic Characterization of Brain Metastases Reveals Branched Evolution and Potential Therapeutic Targets
- (2015) P. K. Brastianos et al. Cancer Discovery
- Next-Generation Sequencing of Stage IV Squamous Cell Lung Cancers Reveals an Association of PI3K Aberrations and Evidence of Clonal Heterogeneity in Patients with Brain Metastases
- (2015) P. K. Paik et al. Cancer Discovery
- Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy
- (2015) Zeynep Eroglu et al. Therapeutic Advances in Medical Oncology
- Stereotactic Radiosurgery With or Without Whole-Brain Radiotherapy for Brain Metastases
- (2015) Hidefumi Aoyama et al. JAMA Oncology
- Incidence of central nervous system metastases in patients with HER2-positive metastatic breast cancer treated with pertuzumab, trastuzumab, and docetaxel: results from the randomized phase III study CLEOPATRA
- (2014) S. M. Swain et al. ANNALS OF ONCOLOGY
- Three-year follow-up of advanced melanoma patients who received ipilimumab plus fotemustine in the Italian Network for Tumor Biotherapy (NIBIT)-M1 phase II study
- (2014) A. M. Di Giacomo et al. ANNALS OF ONCOLOGY
- ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials
- (2014) M. J. Sorich et al. ANNALS OF ONCOLOGY
- Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†
- (2014) M. Piccart et al. ANNALS OF ONCOLOGY
- Role of the Neural Niche in Brain Metastatic Cancer
- (2014) J. Termini et al. CANCER RESEARCH
- Indications and limitations of chemotherapy and targeted agents in non-small cell lung cancer brain metastases
- (2014) Stefan Zimmermann et al. CANCER TREATMENT REVIEWS
- Can diffusion-weighted imaging be used to differentiate brain abscess from other ring-enhancing brain lesions? A meta-analysis
- (2014) X.-X. Xu et al. CLINICAL RADIOLOGY
- BRAF alterations in brain tumours
- (2014) Anna Sophie Berghoff et al. CURRENT OPINION IN NEUROLOGY
- Napsin A is a useful marker for metastatic adenocarcinomas of pulmonary origin
- (2014) Moon-Young Kim et al. HISTOPATHOLOGY
- Molecular Biology of Brain Metastasis
- (2014) Konstantina Svokos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hippocampal-Avoidance Whole-Brain Radiation Therapy: A New Standard for Patients With Brain Metastases?
- (2014) John H. Suh JOURNAL OF CLINICAL ONCOLOGY
- Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
- (2014) Vinai Gondi et al. JOURNAL OF CLINICAL ONCOLOGY
- Sensitive Detection of EGFR Mutations in Cerebrospinal Fluid from Lung Adenocarcinoma Patients with Brain Metastases
- (2014) Haihong Yang et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- LINAC-based stereotactic radiosurgery to the brain with concurrent vemurafenib for melanoma metastases
- (2014) Kamran A. Ahmed et al. JOURNAL OF NEURO-ONCOLOGY
- Intracranial control and radiographic changes with adjuvant radiation therapy for resected brain metastases: whole brain radiotherapy versus stereotactic radiosurgery alone
- (2014) Kirtesh R. Patel et al. JOURNAL OF NEURO-ONCOLOGY
- Fractionated stereotactic radiosurgery for patients with brain metastases
- (2014) Giuseppe Minniti et al. JOURNAL OF NEURO-ONCOLOGY
- Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
- (2014) Siow Ming Lee et al. JNCI-Journal of the National Cancer Institute
- Discoidin Domain Receptor 2 Signaling Networks and Therapy in Lung Cancer
- (2014) Leo S. Payne et al. Journal of Thoracic Oncology
- Safety and activity of alectinib against systemic disease and brain metastases in patients with crizotinib-resistant ALK-rearranged non-small-cell lung cancer (AF-002JG): results from the dose-finding portion of a phase 1/2 study
- (2014) Shirish M Gadgeel et al. LANCET ONCOLOGY
- Role of the endothelin axis in astrocyte- and endothelial cell-mediated chemoprotection of cancer cells
- (2014) Seung Wook Kim et al. NEURO-ONCOLOGY
- Ceritinib in ALK-Rearranged Non–Small-Cell Lung Cancer
- (2014) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
- (2014) James Larkin et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Value of Diffusion Tensor Imaging in Differentiating High-Grade Gliomas from Brain Metastases: A Systematic Review and Meta-Analysis
- (2014) Rui Jiang et al. PLoS One
- Human breast cancer metastases to the brain display GABAergic properties in the neural niche
- (2014) J. Neman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR-TKI therapy for patients with brain metastases from non-small-cell lung cancer: a pooled analysis of published data
- (2014) Conghua Xie et al. OncoTargets and Therapy
- Systematic Review: Anti–Epidermal Growth Factor Receptor Treatment Effect Modification byKRASMutations in Advanced Colorectal Cancer
- (2013) Issa J. Dahabreh et al. ANNALS OF INTERNAL MEDICINE
- Molecular Profiling of Tumor Cells in Cerebrospinal Fluid and Matched Primary Tumors from Metastatic Breast Cancer Patients with Leptomeningeal Carcinomatosis
- (2013) M. J. M. Magbanua et al. CANCER RESEARCH
- A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer
- (2013) Pia Bükmann Larsen et al. CANCER TREATMENT REVIEWS
- A systematic review of dual targeting in HER2-positive breast cancer
- (2013) Iben Kümler et al. CANCER TREATMENT REVIEWS
- Targeting the MET gene for the treatment of non-small-cell lung cancer
- (2013) F. Gelsomino et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Targeted Therapies in Brain Metastases
- (2013) Nancy U. Lin Current Treatment Options in Neurology
- Vemurafenib in patients with BRAFV600 mutation-positive melanoma with symptomatic brain metastases: Final results of an open-label pilot study
- (2013) Reinhard Dummer et al. EUROPEAN JOURNAL OF CANCER
- A Phase 3 Trial of Whole Brain Radiation Therapy and Stereotactic Radiosurgery Alone Versus WBRT and SRS With Temozolomide or Erlotinib for Non-Small Cell Lung Cancer and 1 to 3 Brain Metastases: Radiation Therapy Oncology Group 0320
- (2013) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- The Abscopal Effect Associated With a Systemic Anti-melanoma Immune Response
- (2013) Emily F. Stamell et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Risk of Leptomeningeal Disease in Patients Treated With Stereotactic Radiosurgery Targeting the Postoperative Resection Cavity for Brain Metastases
- (2013) Banu Atalar et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Salvage Radiosurgery for Brain Metastases: Prognostic Factors to Consider in Patient Selection
- (2013) Goldie Kurtz et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer
- (2013) James W. Welsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical outcomes of patients treated with a second course of stereotactic radiosurgery for locally or regionally recurrent brain metastases after prior stereotactic radiosurgery
- (2013) Daniel H. Kim et al. JOURNAL OF NEURO-ONCOLOGY
- Vemurafenib and radiation therapy in melanoma brain metastases
- (2013) Ashwatha Narayana et al. JOURNAL OF NEURO-ONCOLOGY
- CNS metastases in non-small-cell lung cancer: Current role of EGFR-TKI therapy and future perspectives
- (2013) Lars Arne Berger et al. LUNG CANCER
- ALK gene translocations and amplifications in brain metastases of non-small cell lung cancer
- (2013) Matthias Preusser et al. LUNG CANCER
- High rate of FGFR1 amplifications in brain metastases of squamous and non-squamous lung cancer
- (2013) Matthias Preusser et al. LUNG CANCER
- Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery
- (2013) Maya Mathew et al. MELANOMA RESEARCH
- Bevacizumab as a treatment for radiation necrosis of brain metastases post stereotactic radiosurgery
- (2013) Dustin Boothe et al. NEURO-ONCOLOGY
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial
- (2013) P. D. Brown et al. NEURO-ONCOLOGY
- Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma
- (2013) Omid Hamid et al. NEW ENGLAND JOURNAL OF MEDICINE
- Population-based outcomes of boost versus salvage radiosurgery for brain metastases after whole brain radiotherapy
- (2013) Fred Hsu et al. RADIOTHERAPY AND ONCOLOGY
- In Search of the Ideal Immunopanel to Distinguish Metastatic Mammary Carcinoma From Primary Lung Carcinoma
- (2013) Kathy R. Kawaguchi et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Concurrent Radiotherapy and Ipilimumab Immunotherapy for Patients with Melanoma
- (2013) C. A. Barker et al. Cancer Immunology Research
- Ipilimumab and radiation therapy for melanoma brain metastases
- (2013) Ann W. Silk et al. Cancer Medicine
- Brain metastases: pathobiology and emerging targeted therapies
- (2012) Matthias Preusser et al. ACTA NEUROPATHOLOGICA
- Leukoencephalopathy after whole-brain radiation therapy plus radiosurgery versus radiosurgery alone for metastatic lung cancer
- (2012) Edward A. Monaco et al. CANCER
- Therapeutic Implications of KIT in Melanoma
- (2012) Michael A. Postow et al. CANCER JOURNAL
- Cerebrospinal Fluid Concentrations of Gefitinib in Patients With Lung Adenocarcinoma
- (2012) Jing Zhao et al. Clinical Lung Cancer
- Brain metastasis
- (2012) Matthias Preusser et al. CURRENT OPINION IN NEUROLOGY
- Effect of cancer therapy on neural stem cells
- (2012) Erin Gibson et al. CURRENT OPINION IN ONCOLOGY
- Targeted therapy in brain metastasis
- (2012) Riccardo Soffietti et al. CURRENT OPINION IN ONCOLOGY
- Brain metastases as the first symptom of lung cancer: a clinical study from an Asian medical center
- (2012) Jia Jin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- (2012) Kristin Bergethon et al. JOURNAL OF CLINICAL ONCOLOGY
- A European Organisation for Research and Treatment of Cancer Phase III Trial of Adjuvant Whole-Brain Radiotherapy Versus Observation in Patients With One to Three Brain Metastases From Solid Tumors After Surgical Resection or Radiosurgery: Quality-of-Life Results
- (2012) Riccardo Soffietti et al. JOURNAL OF CLINICAL ONCOLOGY
- EGFR mutation status in brain metastases of non-small cell lung carcinoma
- (2012) Fanny Burel-Vandenbos et al. JOURNAL OF NEURO-ONCOLOGY
- Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival
- (2012) Jonathan P. S. Knisely et al. JOURNAL OF NEUROSURGERY
- Diagnostic Performance of 18F-FET PET in Newly Diagnosed Cerebral Lesions Suggestive of Glioma
- (2012) M. Rapp et al. JOURNAL OF NUCLEAR MEDICINE
- Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
- (2012) David Neal Franz et al. LANCET
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Dabrafenib in patients with Val600Glu or Val600Lys BRAF-mutant melanoma metastatic to the brain (BREAK-MB): a multicentre, open-label, phase 2 trial
- (2012) Georgina V Long et al. LANCET ONCOLOGY
- Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study
- (2012) Thomas Bachelot et al. LANCET ONCOLOGY
- Combined Therapy with Mutant-Selective EGFR Inhibitor and Met Kinase Inhibitor for Overcoming Erlotinib Resistance in EGFR-Mutant Lung Cancer
- (2012) T. Nakagawa et al. MOLECULAR CANCER THERAPEUTICS
- Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence data
- (2012) Faith G. Davis et al. NEURO-ONCOLOGY
- Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations
- (2012) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Iodine-125 brachytherapy for brain tumours - a review
- (2012) Silke B Schwarz et al. Radiation Oncology
- Impact of BRAF mutation and microsatellite instability on the pattern of metastatic spread and prognosis in metastatic colorectal cancer
- (2011) Ben Tran et al. CANCER
- A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases
- (2011) May Tsao et al. CANCER
- Expression of antigen processing and presenting molecules in brain metastasis of breast cancer
- (2011) Yan Liu et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tissue confirmation of disease recurrence in breast cancer patients: Pooled analysis of multi-centre, multi-disciplinary prospective studies
- (2011) Eitan Amir et al. CANCER TREATMENT REVIEWS
- Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in the Treatment of Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Metastatic to the Brain
- (2011) M. Jamal-Hanjani et al. CLINICAL CANCER RESEARCH
- Phase I Clinical Trial Outcomes in 93 Patients with Brain Metastases: The MD Anderson Cancer Center Experience
- (2011) A. M. Tsimberidou et al. CLINICAL CANCER RESEARCH
- Prognostic Factors for Survival in Patients Treated With Stereotactic Radiosurgery for Recurrent Brain Metastases After Prior Whole Brain Radiotherapy
- (2011) Jorge A. Caballero et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- CSF Concentration of the Anaplastic Lymphoma Kinase Inhibitor Crizotinib
- (2011) Daniel B. Costa et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and clinical activity of ipilimumab in melanoma patients with brain metastases
- (2011) Jeffrey S. Weber et al. MELANOMA RESEARCH
- Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
- (2011) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors
- (2010) Andres Server et al. ACTA RADIOLOGICA
- Prognostic factors for survival in melanoma patients with brain metastases
- (2010) Michael A. Davies et al. CANCER
- Macrophage Diversity Enhances Tumor Progression and Metastasis
- (2010) Bin-Zhi Qian et al. CELL
- Interaction between lung cancer cells and astrocytes via specific inflammatory cytokines in the microenvironment of brain metastasis
- (2010) Toshihiro Seike et al. CLINICAL & EXPERIMENTAL METASTASIS
- Brain metastases from lung cancer responding to erlotinib: the importance of EGFR mutation
- (2010) R. Porta et al. EUROPEAN RESPIRATORY JOURNAL
- Hallmarks of cancer: Interactions with the tumor stroma
- (2010) Kristian Pietras et al. EXPERIMENTAL CELL RESEARCH
- Intracranial Metastatic Disease Spares the Limbic Circuit: A Review of 697 Metastatic Lesions in 107 Patients
- (2010) James C. Marsh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adjuvant Whole-Brain Radiotherapy Versus Observation After Radiosurgery or Surgical Resection of One to Three Cerebral Metastases: Results of the EORTC 22952-26001 Study
- (2010) Martin Kocher et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic radiosurgery as primary and salvage treatment for brain metastases from breast cancer
- (2010) Douglas Kondziolka et al. JOURNAL OF NEUROSURGERY
- Activation of MET by Gene Amplification or by Splice Mutations Deleting the Juxtamembrane Domain in Primary Resected Lung Cancers
- (2010) Ryoichi Onozato et al. Journal of Thoracic Oncology
- The Molecular Pathobiology of Metastasis to the Brain: A Review
- (2010) Kara D. Beasley et al. NEUROSURGERY CLINICS OF NORTH AMERICA
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- Mechanics, malignancy, and metastasis: The force journey of a tumor cell
- (2009) Sanjay Kumar et al. CANCER AND METASTASIS REVIEWS
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- Intracerebral metastasis showing restricted diffusion: Correlation with histopathologic findings
- (2009) G. Duygulu et al. EUROPEAN JOURNAL OF RADIOLOGY
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients
- (2009) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy
- (2009) M. Maschio et al. JOURNAL OF NEURO-ONCOLOGY
- The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Minesh P. Mehta et al. JOURNAL OF NEURO-ONCOLOGY
- The role of prophylactic anticonvulsants in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Tom Mikkelsen et al. JOURNAL OF NEURO-ONCOLOGY
- The role of steroids in the management of brain metastases: a systematic review and evidence-based clinical practice guideline
- (2009) Timothy C. Ryken et al. JOURNAL OF NEURO-ONCOLOGY
- Stereotactic radiosurgery for metastatic brain tumors: a comprehensive review of complications
- (2009) Brian J. Williams et al. JOURNAL OF NEUROSURGERY
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
- (2009) Eric L Chang et al. LANCET ONCOLOGY
- Salvage stereotactic radiosurgery effectively treats recurrences from whole-brain radiation therapy
- (2008) Samuel T. Chao et al. CANCER
- Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma
- (2008) Michael B. Atkins et al. CANCER
- Brain metastases: current management and new developments
- (2008) Riccardo Soffietti et al. CURRENT OPINION IN ONCOLOGY
- Whole brain radiotherapy plus stereotactic radiosurgery (WBRT+SRS) versus surgery plus whole brain radiotherapy (OP+WBRT) for 1–3 brain metastases: Results of a matched pair analysis
- (2008) Dirk Rades et al. EUROPEAN JOURNAL OF CANCER
- Motexafin Gadolinium Combined With Prompt Whole Brain Radiotherapy Prolongs Time to Neurologic Progression in Non–Small-Cell Lung Cancer Patients With Brain Metastases: Results of a Phase III Trial
- (2008) Minesh P. Mehta et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Major Response to Imatinib Mesylate in KIT-Mutated Melanoma
- (2008) F. Stephen Hodi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Trial of Lapatinib for Brain Metastases in Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer
- (2008) Nancy U. Lin et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa
- (2008) Dima Suki et al. JOURNAL OF NEUROSURGERY
- A New Prognostic Index and Comparison to Three Other Indices for Patients With Brain Metastases: An Analysis of 1,960 Patients in the RTOG Database
- (2007) Paul W. Sperduto et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now